Clinical Research Directory
Browse clinical research sites, groups, and studies.
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
Sponsor: Immunis.AI
Summary
A multi-center, prospective active surveillance registry trial assessing the performance of a non-invasive blood test for indolent prostate cancer disease management.
Official title: A Multi-center, Prospective Active Surveillance Registry Trial Assessing the Performance of a Non-invasive Immunogenomic Blood Test for Indolent Prostate Cancer Disease Management.
Key Details
Gender
MALE
Age Range
40 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2019-09-09
Completion Date
2029-09-30
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Interventions
Subtraction Normalized Expression of Phagocytes Blood Test
Non-invasive blood based immunogenomic assay that targets RNA sequencing to identify disease and disease aggressiveness
Locations (1)
Comprehensive Urology
Royal Oak, Michigan, United States